Stans, Switzerland, December 9, 2013 - Ms Maxime Stevens joined PRINT as CBDO (Chief Business Development Officer) in April 2013, tasked with the responsibility of strategically restructuring and realigning THERAMetrics holding AG (Group), preparing the foundations for long-term growth, operational excellence and the expansion of new geographic opportunities. In July 2013 Ms Maxime Stevens became PRINT CEO. PRINT announces this month the nomination of Ms Maxime Stevens as new member of the Board of Directors. During the last eight months approximately € 10 million in new contracts and amendments have been awarded to the Group, with additional substantial new contracts expected to be signed still this year. This reflects the significant strides of improvement already achieved in the last few months by the Group as an entirety; and the measures of support and confidence rewarded by the Sponsors. Recent awards include those from Sponsors from newer geographical arenas for the Group, including Israel, where Maxime was presenting at LifeSciences Israel only few weeks ago. Equally significant is the rapidly increasing pipeline of the Group, now exceeding € 35 million, much of this will be realised in 2014, thus bolstering both revenues and backlogs. About THERAMetrics holding AG THERAMetrics holding AG is a tech-based Contract Research & Development Organisation dedicated to provide a full range of technological solutions through the entire value chain of drug discovery and development. The company, listed at the SIX Swiss Exchange (TMX) and located in Stans (Switzerland). For further information please contact THERAMetrics holding AG Investor and External Relations Tel.: +41 79 285 37 81 [email protected]